By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche is licensing technology from the Biodesign Institute at Arizona State University and the Columbia University Nanoscience Center for the development of a new DNA sequencing system, Roche and the Arizona Technology Enterprises announced today.

The technologies being licensed were developed by Stuart Lindsay at the Biodesign Institute and Colin Nuckolls from Columbia and include "specialized approaches" for DNA base sensing and reading.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.